Skip to main content

Advertisement

Log in

Pulmonary Alveolar Proteinosis Secondary to Pneumocystis jiroveci Infection in an Infant with Common Variable Immunodeficiency

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The authors report an infant with common variable immunodeficiency (CVID) with Pneumocystis pneumonia who developed secondary pulmonary alveolar proteinosis (PAP). This is the youngest infant reported to develop PAP secondary to Pneumocystis infection in an immunocompromised state. He was effectively managed with anti-microbials, frequent lung toilet, optimized mechanical ventilation, and supportive care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

PAP:

Pulmonary alveolar proteinosis

MSG:

Major surface glycoprotein

GM-CSF:

Granulocyte-macrophage colony-stimulating factor

IVIg:

Intravenous immunoglobulin

References

  1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958;258:1123–42.

    Article  CAS  PubMed  Google Scholar 

  2. Tran Van Nhieu J, Vojtek AM, Bernaudin JF, Escudier E, Fleury-Feith J. Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients. Chest. 1990;98:801–5.

    Article  CAS  PubMed  Google Scholar 

  3. Yong PF, Thaventhiran JE, Grimbacher B. “A rose is a rose is a rose,” but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47–107.

    Article  CAS  PubMed  Google Scholar 

  4. Huizar I, Kavuru MS. Alveolar proteinosis syndrome: Pathogenesis, diagnosis, and management. Curr Opin Pulm Med. 2009;15:491–8.

    Google Scholar 

  5. Carre PC, Didier AP, Pipy BR, et al. The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages. Am Rev Respir Dis. 1990;142:1068–72.

    Article  CAS  PubMed  Google Scholar 

  6. Gonzalez-Rothi RJ, Harris JO. Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages. Chest. 1986;90:656–61.

    Article  CAS  PubMed  Google Scholar 

  7. Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: The rôle of electron microscopy. Thorax. 1975;30:121–32.

    Google Scholar 

  8. Patiroglu T, Akyildiz B, Patiroglu TE, Gulmez IY. Recurrent pulmonary alveolar proteinosis secondary to agammaglobulinemia. Pediatr Pulmonol. 2008;43:710–3.

    Article  PubMed  Google Scholar 

  9. Borie R, Danel C, Debray MP, et al. Pulmonary alveolar proteinosis. Eur Respir Rev. 2011;20:98–107.

    Article  CAS  PubMed  Google Scholar 

  10. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994;91:5592–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rakesh Lodha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raj, D., Bhutia, T.D., Mathur, S. et al. Pulmonary Alveolar Proteinosis Secondary to Pneumocystis jiroveci Infection in an Infant with Common Variable Immunodeficiency. Indian J Pediatr 81, 929–931 (2014). https://doi.org/10.1007/s12098-013-1027-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-013-1027-6

Keywords

Navigation